SPI

SPI handeln
18.551,09 PKT +155,85 PKT +0,85 %
finanzen.net zero
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Smartphone

WKN 998750

ISIN CH0009987501


Analysen zu SPI-Werten

Datum Rating Analyst
15.09.11 Zurich Insurance hold ING
15.09.11 Kühne + Nagel International hold Vontobel Research
15.09.11 Zurich Insurance buy Société Générale Group S.A. (SG)
15.09.11 Lonza hold Vontobel Research
14.09.11 Temenos buy UniCredit Research
14.09.11 Novartis buy Société Générale Group S.A. (SG)
14.09.11 Sonova hold Vontobel Research
14.09.11 Novartis buy Vontobel Research
14.09.11 Lonza hold Vontobel Research
13.09.11 Burckhardt Compression reduce Vontobel Research
12.09.11 Newron PharmaceuticalsAz. buy Vontobel Research
12.09.11 Swiss Re buy Vontobel Research
12.09.11 Swatch (I) buy Vontobel Research
12.09.11 Lonza hold Vontobel Research
09.09.11 Novartis outperform Credit Suisse Group
09.09.11 UBS overweight Morgan Stanley
09.09.11 Julius Bär equal-weight Morgan Stanley
09.09.11 Sika buy UBS AG
09.09.11 ABB (Asea Brown Boveri) buy UBS AG
09.09.11 Sika buy Vontobel Research
09.09.11 Newron PharmaceuticalsAz. buy Vontobel Research
09.09.11 Burckhardt Compression reduce Vontobel Research
09.09.11 Swatch (I) buy Vontobel Research
09.09.11 Lonza hold Vontobel Research
08.09.11 Givaudan overweight J.P. Morgan Cazenove
08.09.11 Holcim buy UBS AG
08.09.11 Holcim neutral J.P. Morgan Cazenove
08.09.11 ABB (Asea Brown Boveri) overweight J.P. Morgan Cazenove
08.09.11 Holcim neutral Nomura
08.09.11 Swiss Prime Site hold Vontobel Research
08.09.11 Novartis buy Vontobel Research
08.09.11 Swatch (I) buy Vontobel Research
08.09.11 UBS hold Vontobel Research
07.09.11 UBS outperform Keefe, Bruyette & Woods, Inc.
07.09.11 UBS outperform Keefe, Bruyette & Woods, Inc.
07.09.11 Richemont buy Citigroup Corp.
07.09.11 Clariant hold Citigroup Corp.
07.09.11 Nestlé hold UniCredit Research
07.09.11 Straumann underperform Macquarie Research
07.09.11 Clariant underperform Macquarie Research